- Home
- DERM vs ATOM Comparison
DERM vs ATOM Comparison
Compare DERM & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- ATOM
- Stock Information
- Founded
- DERM 2014
- ATOM 2001
- Country
- DERM United States
- ATOM United States
- Employees
- DERM N/A
- ATOM N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- ATOM Semiconductors
- Sector
- DERM Health Care
- ATOM Technology
- Exchange
- DERM Nasdaq
- ATOM Nasdaq
- Market Cap
- DERM 190.7M
- ATOM 155.4M
- IPO Year
- DERM 2021
- ATOM 2016
- Fundamental
- Price
- DERM $7.54
- ATOM $4.88
- Analyst Decision
- DERM Strong Buy
- ATOM
- Analyst Count
- DERM 3
- ATOM 0
- Target Price
- DERM $12.67
- ATOM N/A
- AVG Volume (30 Days)
- DERM 92.2K
- ATOM 496.3K
- Earning Date
- DERM 11-11-2025
- ATOM 10-28-2025
- Dividend Yield
- DERM N/A
- ATOM N/A
- EPS Growth
- DERM N/A
- ATOM N/A
- EPS
- DERM N/A
- ATOM N/A
- Revenue
- DERM $56,397,000.00
- ATOM $49,000.00
- Revenue This Year
- DERM $26.25
- ATOM N/A
- Revenue Next Year
- DERM $52.96
- ATOM $700.00
- P/E Ratio
- DERM N/A
- ATOM N/A
- Revenue Growth
- DERM N/A
- ATOM N/A
- 52 Week Low
- DERM $3.54
- ATOM $2.43
- 52 Week High
- DERM $8.90
- ATOM $17.55
- Technical
- Relative Strength Index (RSI)
- DERM 59.93
- ATOM 68.33
- Support Level
- DERM $6.85
- ATOM $4.61
- Resistance Level
- DERM $7.45
- ATOM $4.74
- Average True Range (ATR)
- DERM 0.30
- ATOM 0.41
- MACD
- DERM 0.04
- ATOM 0.14
- Stochastic Oscillator
- DERM 100.00
- ATOM 76.92
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About ATOM Atomera Incorporated
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.